Article
Roche drops midphase hepatitis B and eye disease programs in quarterly pipeline clearout
Rating:
0.0
Views:
34
Likes:
1
Library:
1
Roche has taken the scissors to its clinical development pipeline, snipping off phase 2 studies of potential treatments for hepatitis B virus and geographic atrophy in the quarterly cull of its inv | Roche has taken the scissors to its clinical development pipeline, snipping off phase 2 studies of potential treatments for hepatitis B virus and geographic atrophy in the quarterly cull of its investigational assets.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value